4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001714899-23-000107
Director sold 1,666 shares at an average $29.84 ($49,709)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| SATO VICKI L Director | 2023-06-28 | Sale 10b5-1 | −552 | $29.55 | $16,312 | 135,817 | D |
| SATO VICKI L Director | 2023-06-28 | Sale 10b5-1 | −1,114 | $29.98 | $33,398 | 134,703 | D |
| Open-market sales · 1,666 sh · avg $29.84 · $49,709 | |||||||
Loading xslF345X04/wk-form4_1688160091.xml…